Nobel Prize, Big Bang, Inflation 01:30:20 Cosmic Microwave Background Radiation, BICEP 01:37:58 Father & Son Relationship, Science & Rewards 01:44:06 Loss, Mentor 01:49:55 Antarctica, South Pole 01:56:49 Light & Heat Pollution, South Pole 02:01:09 Prize Pursuit, First Discovery
10.3390/biomedicines10020289 414 StrandwitzP.KimK
In short, coverage for Foundayo can be limited, inconsistent, and difficult to obtain
They are liquid, injectable medications that help lower blood sugars and A1c levels and are taken subcutaneously (just under the skin) in areas such as the abdomen, thigh, or upper arm
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release